ALGS SCHEDULE 13G/A: SEC filing

Alyeska Investment Group, L.P. and affiliated reporting persons

Filed with the SEC on · accession 0001172661-26-005360

ALGS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -20.7% by the first close after the filing.

Summary of the filing

Alyeska Investment Group, L.P. and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of 352,472 shares (5.64%) of Aligos Therapeutics common stock, held via warrants, as of September 30, 2026.

Key details

Shares of common stock beneficially owned (issuable upon exercise of warrants)$352K
Percentage of class beneficially ownedPCT 6
Issuer of the securitiesAligos Therapeutics, Inc.
Reporting person / investment managerAlyeska Investment Group, L.P.
Reporting personAlyeska Fund GP, LLC
Direct holder of the sharesAlyeska Master Fund, L.P.
Chief executive officer of alyeska investment group, l.p.Anand Parekh
Chief financial officer of alyeska investment group, l.p. and alyeska fund gp, llcJason Bragg

How ALGS stock reacted

Close before

$2.10

Nov 13, 2026

First close after

-20.71%

$1.67

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ALGS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ALGS?

Click here

Frequently asked questions

What did ALGS file with the SEC on Nov 16, 2026?

ALGS filed a SCHEDULE 13G/A (SEC filing). Alyeska Investment Group, L.P. and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of 352,472 shares (5.64%) of Aligos Therapeutics common stock, held via warrants, as of September 30, 2026.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ALGS stock react to this filing?

ALGS closed at $2.10 before the filing and $1.67 on Nov 16, 2026 (-20.71%).

Other ALGS SEC filings

Get alerts when ALGS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days